Annual report pursuant to Section 13 and 15(d)

Consolidated Balance Sheets

v3.23.1
Consolidated Balance Sheets - USD ($)
$ in Thousands
Dec. 31, 2022
Dec. 31, 2021
Current assets:    
Cash and cash equivalents $ 32,190 $ 24,983
Marketable securities, current 28,859 118,061
Prepaid expenses 3,459 3,917
Other current assets 3,790 1,254
Total current assets 68,298 148,215
Marketable securities, non-current 0 8,986
Operating lease right-of-use assets 11,132 8,608
Property and equipment, net 14,632 19,309
Other assets 3,486 7,244
Total assets 97,548 192,362
Current liabilities:    
Accounts payable 504 1,612
Accrued liabilities 8,823 9,515
Deferred revenue, current 45,573 32,937
Other current liabilities 2,182 2,606
Total current liabilities 57,082 46,670
Deferred revenue, long-term 5,904 33,350
Long-term debt, net of current portion 36,168 35,491
Operating lease liabilities 12,231 9,564
Other liabilities 1,295 1,625
Total liabilities 112,680 126,700
Commitments and contingencies (Note 10) 0 0
Stockholders’ equity    
Preferred stock, $0.001 par value: Authorized: 2,000,000 shares at December 31, 2022 and December 31, 2021; issued and outstanding: 250 shares at December 31, 2022 and December 31, 2021 0 0
Common stock, $0.001 par value: Authorized: 150,000,000 shares at December 31, 2022 and December 31, 2021; issued and outstanding: 56,351,647 shares at December 31, 2022 and 56,305,049 shares at December 31, 2021 56 56
Additional paid-in capital 429,646 417,704
Accumulated other comprehensive loss (66) (48)
Accumulated deficit (444,768) (352,050)
Total stockholders’ (deficit) equity (15,132) 65,662
Total liabilities and stockholders’ (deficit) equity $ 97,548 $ 192,362